Born on December 15, 1934 in Pittsburgh, PA, her landscapes are characterized by their intense color and elaborate detail. Exhibiting regularly with DC Moore Gallery in New York, the artist is also ...

Dressed in an unbuttoned green suede shirt and slim-fit jeans, Glenn flashed a smile as he strolled ... it came to promoting Anyone But You. 'I don't have the mental capacity to pull anything ...

In truth, the people we consider beyond reproach are capable of making boneheaded decisions just like anyone else. For instance, one of the most acclaimed auteurs of the last four decades once ...

The Jets have had nine consecutive losing seasons and haven’t been to the playoffs since 2010. At times it has felt like no one can turn them around. The Jets have to hope Campbell is correct that ...

Daily Show host Michael Kosta then asked Glenn specifically about his mysterious character. “We don’t know if he killed the dad, if he’s Walton Goggin’s dad… What can you tell us ...

Aaron Glenn is the head coach who can finally win ... coaches and he'll bring the right kind of players. Look, if he can't, nobody can, that's my opinion." The Jets have had nine consecutive ...

everybody is a champ," Glenn said. "Everybody is going to the Super Bowl. But, when the season starts, that really tells you who you are. So I tell our guys that we don't have to talk. We don't ...

Regardless, Glenn doesn't really care either way. It's a clean slate in the coach's mind for Wilson. In discussing his running back including the likes of Breece Hall and Braelon Allen ...

Aaron Glenn addressed the media and was asked about Wilson and the dysfunction of last year and doesn't sound concerned by any means and instead made it clear he's had good conversations with the ...

New York Jets head coach Aaron Glenn took part in a yearly NFL tradition for the first time this past week. Each year at the NFL owners meetings... it's not just the owners of all 32 teams in ...

Eli Lilly’s CEO David Ricks could sign more deals to strengthen its pipeline of cancer drugs, but is leaving gene cell-based CAR-T oncology drugs and rare disease gene therapies for others to ...